James Harden - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock James Harden's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
James Harden
Verified
Editor-in-Chief, CRISPR Medicine News
Ireland
Beats
Hard News , Entertainment , Education , Sports
politics, engineering, sports
Content
By James Harden| bitesizebio.com@ Gene expression analysis plays a pivotal role in a wide range of studies, including biomedical analysis and diagnostics. Of all the methods available for gene expression analysis, quantitative real-time PCR (qRT-PCR) is the most rapid, sensitive, and accurate to measure mRNA, and its use in clinical diagnostics is rising steadily. RNA quality entails both purity and integrity.
By James Harden| bitesizebio.com@ The Scene of the CrimeThe body of a woman is found behind an abandoned warehouse on the outskirts of town. Forensic experts carry out a technical examination of the scene and suggest strangulation as the cause of death. The absence of bloody footprints or weapons means there are no obvious leads to the killer. The experts carefully dust down the body and its surroundings for fingerprints, hairs and clothing fibres, possibly containing skin and bodily fluids.
By James Harden| bitesizebio.com@ Gene expression analysis plays a pivotal role in a wide range of studies, including biomedical analysis and diagnostics. Of all the methods available for gene expression analysis, quantitative real-time PCR (qRT-PCR) is the most rapid, sensitive, and accurate to measure mRNA, and its use in clinical diagnostics is rising steadily. RNA quality entails both purity and integrity.
Company Info
CRISPR Medicine News
CRISPR Medicine News (CMN) is a media platform dedicated to the field of genetic medicine, gene therapy, and CRISPR-based genome editing technologies. It serves as an information hub, providing in-depth interviews, news, and analyses to keep stakeholders updated on advancements in CRISPR therapeutics. CMN focuses on news reporting, expert interviews, and educational content related to CRISPR technology. It covers topics such as clinical trial progress, regulatory developments, and industry best practices. The platform targets a professional audience, including researchers, biotech and pharmaceutical professionals, regulatory experts, and healthcare providers, all of whom are engaged in the evolving landscape of CRISPR therapies.
Founded: 2019